₹ 10.3
NAV (Jul 29)
View Less
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
Expense Ratio | 0.66 % |
Launched <1Y | 2024-12-06 |
AUM in Crores | 111.8 |
ISIN | INF663L01Z45 |
Lock-in (days) | No Lock-in |
Benchmark | BSE Healthcare Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation | - |
Beta | - |
Sharpe Ratio | - |
Healthcare
85.84%Services
4.58%Insurance
2.87%Chemicals
2.02%Fund Name | Fund Size | |
---|---|---|
₹ 110,392 cr | ||
₹ 72,336 cr | ||
₹ 26,848 cr | ||
₹ 30,616 cr | ||
₹ 79,584 cr |